Josh Enomoto

Josh Enomoto

InvestorPlace Contributor

Brokering multi-million-dollar deals with some of the world’s biggest companies and providing in-depth marketing analyses, Josh Enomoto takes his firsthand knowledge of the corporate boardroom and delivers them across several media outlets. In addition to his work at InvestorPlace, Josh contributes content for Benzinga, TipRanks, EmergingGrowth and Blockster. He is also a guest expert at CGTN America.

While leaving no stone unturned regarding sector coverage, Josh has written extensively about cryptocurrencies. You can follow him on Blockster, a crypto-centric social media platform and on LinkedIn.

Recent Articles

The Top 8 Penny Stocks to Buy for August Uncertainty

By Josh Enomoto, InvestorPlace Contributor

Penny stocks will always be risky. That said, with the huge disconnect we’re seeing in the markets, now may be a time to gamble.

A Robinhood Pop Doesn’t Make Ocugen Stock a Smart Investment

By Josh Enomoto, InvestorPlace Contributor

A disappointment throughout most of this year, OCGN stock recently shot higher. It’s very possible that enthusiastic but misguided speculators are behind this move.

How the Coronavirus and Competition Threaten Carnival

By Josh Enomoto, InvestorPlace Contributor

CCL stock was starting to look interesting. However, a cruise ship outbreak in Norway poses major challenges for the entire industry.

It’s Not Just Millenials’ Robinhood Trading That’s Driving Hertz Stock

By Josh Enomoto, InvestorPlace Contributor

Looking at Hertz stock from all angles, it’s not just dumb speculation but also consumer behavioral shifts that could be supporting the bankrupt company. However, that doesn’t make it a good idea.

Invest in Sense Diagnostics Stock for Improved Health Outcomes

By Josh Enomoto, InvestorPlace Contributor

With strokes and traumatic brain injuries being hot topics in the medical industry, many have decided to invest in Sense Diagnostics stock.

Load More